loading
前日終値:
$7.36
開ける:
$7.28
24時間の取引高:
428.08K
Relative Volume:
0.26
時価総額:
$2.26B
収益:
$2.68B
当期純損益:
$-184.45M
株価収益率:
-10.39
EPS:
-0.6805
ネットキャッシュフロー:
$229.23M
1週間 パフォーマンス:
-1.94%
1か月 パフォーマンス:
-18.36%
6か月 パフォーマンス:
-16.53%
1年 パフォーマンス:
+30.44%
1日の値動き範囲:
Value
$7.06
$7.29
1週間の範囲:
Value
$7.01
$7.405
52週間の値動き範囲:
Value
$5.18
$9.475

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
名前
Amneal Pharmaceuticals Inc
Name
セクター
Healthcare (1152)
Name
電話
908-947-3120
Name
住所
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
職員
5,210
Name
Twitter
@amnealpharma
Name
次回の収益日
2024-12-08
Name
最新のSEC提出書
Name
AMRX's Discussions on Twitter

AMRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
7.065 2.26B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
146.43 67.28B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.14 45.61B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.84 45.01B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
13.29 15.64B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
284.31 12.77B 2.76B 1.11B 898.10M 22.77

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-24 アップグレード JP Morgan Neutral → Overweight
2024-09-06 アップグレード JP Morgan Underweight → Neutral
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2021-03-08 アップグレード Goldman Sell → Buy
2020-12-14 アップグレード Barclays Equal Weight → Overweight
2020-12-14 アップグレード Guggenheim Neutral → Buy
2020-07-27 開始されました Goldman Sell
2020-05-12 アップグレード Guggenheim Sell → Neutral
2019-12-12 ダウングレード Raymond James Outperform → Mkt Perform
2019-11-12 ダウングレード JP Morgan Neutral → Underweight
2019-11-07 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-07-22 アップグレード SVB Leerink Mkt Perform → Outperform
2019-07-11 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-07-08 アップグレード Piper Jaffray Neutral → Overweight
2019-06-11 開始されました Barclays Equal Weight
2019-05-21 アップグレード Raymond James Mkt Perform → Strong Buy
2019-03-20 開始されました SunTrust Buy
2019-03-08 ダウングレード SVB Leerink Outperform → Mkt Perform
2018-12-14 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-10-16 ダウングレード SunTrust Buy → Hold
2018-08-13 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-07-23 開始されました Morgan Stanley Overweight
2018-06-22 開始されました B. Riley FBR, Inc. Buy
すべてを表示

Amneal Pharmaceuticals Inc (AMRX) 最新ニュース

pulisher
Apr 18, 2025

Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter - usrecallnews.com

Apr 18, 2025
pulisher
Apr 17, 2025

Even though Amneal Pharmaceuticals (NASDAQ:AMRX) has lost US$78m market cap in last 7 days, shareholders are still up 125% over 5 years - Yahoo Finance

Apr 17, 2025
pulisher
Apr 15, 2025

Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey

Apr 15, 2025
pulisher
Apr 15, 2025

Lobbying Update: $60,000 of AMNEAL PHARMACEUTICALS INC. lobbying was just disclosed - Nasdaq

Apr 15, 2025
pulisher
Apr 14, 2025

10 Best Pharma Stocks to Buy for Long Term Growth - Insider Monkey

Apr 14, 2025
pulisher
Apr 14, 2025

Amneal donates $1.5M this Parkinson’s Awareness Month - NJBIZ

Apr 14, 2025
pulisher
Apr 14, 2025

NY AG reaches $270M multistate opioid settlement with Amneal Pharmaceuticals - Class Action Lawsuits

Apr 14, 2025
pulisher
Apr 11, 2025

Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month - BioSpace

Apr 11, 2025
pulisher
Apr 11, 2025

Amneal's $1.5M Donation Makes Parkinson's Medications More Accessible for Thousands - Stock Titan

Apr 11, 2025
pulisher
Apr 08, 2025

Amneal to Report First Quarter 2025 Results on May 2, 2025 - Bluefield Daily Telegraph

Apr 08, 2025
pulisher
Apr 08, 2025

Amneal Boruzu Subcutaneous Formulation Launch - Clinical Oncology News

Apr 08, 2025
pulisher
Apr 08, 2025

Amneal Earnings Preview: Key Updates Coming May 2 in Q1 2025 Report - Stock Titan

Apr 08, 2025
pulisher
Apr 07, 2025

Amneal’s CREXONT improves sleep in Parkinson’s patients By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal's Combination Drug Shows Improved Sleep Quality In Parkinson's Disease Patients - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease - BioSpace

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal Announces New Data From Phase 3 Study - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

Amneal’s CREXONT improves sleep in Parkinson’s patients - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Breakthrough: New Parkinson's Drug Shows Major Sleep Quality Gains in Phase 3 Trial - Stock Titan

Apr 07, 2025
pulisher
Apr 03, 2025

Amneal Pharmaceuticals (AMRX) Expands Coverage for Parkinson's D - GuruFocus

Apr 03, 2025
pulisher
Apr 03, 2025

Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S. - BioSpace

Apr 03, 2025
pulisher
Apr 03, 2025

Amneal gets expanded coverage for Parkinson’s disease drug - Seeking Alpha

Apr 03, 2025
pulisher
Apr 03, 2025

Amneal Announces Expanded Coverage For Crexont® To Enhance Access For Parkinson'S Disease Patients In The U.S. - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Breakthrough: Amneal's Parkinson's Drug CREXONT Secures Game-Changing Insurance Coverage - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Amneal and Shilpa introduce Boruzu in US for cancer treatment - Yahoo Finance

Apr 02, 2025
pulisher
Apr 01, 2025

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma - The Joplin Globe

Apr 01, 2025
pulisher
Apr 01, 2025

Amneal Launches BORUZU , First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma - Business Wire

Apr 01, 2025
pulisher
Apr 01, 2025

Groundbreaking Cancer Treatment: First Ready-Made Bortezomib Injection Hits Market - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk) - Business Wire

Mar 31, 2025
pulisher
Mar 27, 2025

Myasthenia Gravis Treatment Market Size, Growth Analysis 2031 - openPR

Mar 27, 2025
pulisher
Mar 25, 2025

Insiders At Amneal Pharmaceuticals Sold US$48m In Stock, Alluding To Potential Weakness - simplywall.st

Mar 25, 2025
pulisher
Mar 21, 2025

Amneal Digs Deeper Into GLP-1 Aspirations Following Metsera’s IPO - insights.citeline.com

Mar 21, 2025
pulisher
Mar 19, 2025

Amneal Pharmaceuticals: Shares Still Feel Significantly Undervalued (NASDAQ:AMRX) - Seeking Alpha

Mar 19, 2025
pulisher
Mar 17, 2025

Amneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s Treatment - Markets Insider

Mar 17, 2025
pulisher
Mar 12, 2025

Amneal Pharmaceuticals’ SWOT analysis: generic drug maker’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Amneal Pharmaceuticals’ SWOT analysis: generic drug maker’s stock poised for growth - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Amneal at Barclays Healthcare Conference: Growth and Innovation Insights By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Amneal to Participate at Upcoming March 2025 Investor Conference - BioSpace

Mar 11, 2025
pulisher
Mar 10, 2025

Amneal to Participate at Upcoming Investor Conference - WICZ

Mar 10, 2025
pulisher
Mar 08, 2025

Amneal Pharmaceuticals EVP Jason Daly sells $792,159 in stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 08, 2025

Amneal Pharmaceuticals CFO Tasos Konidaris sells $891,000 in stock By Investing.com - Investing.com India

Mar 08, 2025
pulisher
Mar 08, 2025

Amneal Pharmaceuticals EVP Andrew Boyer sells $1.1 million in stock By Investing.com - Investing.com Canada

Mar 08, 2025
pulisher
Mar 07, 2025

Insider Exodus: Amneal Pharmaceuticals Executives and Directors Offload Massive Stock Holdings - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals EVP Jason Daly sells $792,159 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Teva denied stay in Amneal patent dispute as it appeals to Supreme Court - MLex

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals EVP Andrew Boyer sells $1.1 million in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals CFO Tasos Konidaris sells $891,000 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals director Alva Emily Peterson sells $712,000 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Amneal Pharmaceuticals Executives and Director Sell Shares - TradingView

Mar 07, 2025

Amneal Pharmaceuticals Inc (AMRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$8.425
price down icon 0.71%
$26.79
price down icon 0.70%
$101.29
price down icon 0.09%
$7.54
price down icon 1.06%
$99.60
price down icon 1.63%
$283.84
price down icon 0.07%
大文字化:     |  ボリューム (24 時間):